Short answer
VALHI INC /DE/ (VHI) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $504M (down 5.6% year over year) with net income of −$22M.
Q3 2025 key financials · XBRL
- Revenue
- $504M
- −5.6% YoY · −6.8% QoQ
- Net income
- −$22M
- −138.6% YoY · −2566.7% QoQ
- Operating margin
- 1.7%
- Gross margin
- 12.0%
- EPS (diluted)
- −$0.77
- −138.1% YoY · −2666.7% QoQ
Source: XBRL data from the VALHI INC /DE/ (VHI) Q3 2025 10-Q on SEC EDGAR. USD.
VALHI INC /DE/ Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- No profitability or margin data disclosed in this section
- Chemicals Segment goodwill net value $355.2M as of Sept 30, 2025; no impairment recognized in Q3 2025
- No details on cash position or capital deployment changes included
- Management notes goodwill impairment test involves significant judgment and future recognition of impairment is possible based on market conditions
Risk Factors
- No new or changed risk factors disclosed since 2024 Annual Report risk section
- Most significant risks remain operational exposure in chemical markets and cyclicality of end markets
- Legal risk related to Supplemental Indenture dated Sept 15, 2025, involving Kronos International and Deutsche Bank trustee roles
- Near-term market risk includes commodity price volatility impacting Kronos segment profitability
- Financial risk centered on debt agreements under Supplemental Indenture potentially affecting liquidity and covenant compliance
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other VALHI INC /DE/ quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.